What are the ventilation guidelines for a patient with Extracorporeal Cardiopulmonary Resuscitation (ECCOR2)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ventilation Guidelines in ECCO2R Patients

In patients receiving extracorporeal CO2 removal (ECCO2R), implement ultra-protective ventilation with tidal volumes of 3-4 mL/kg predicted body weight, plateau pressures maintained at 23-25 cmH2O, and PEEP of 4-8 cmH2O (or higher at 10-15 cmH2O), while targeting normocapnia and avoiding hyperventilation. 1, 2, 3

Core Ventilation Parameters During ECCO2R

Tidal Volume Strategy

  • Target tidal volume of 3-4 mL/kg predicted body weight when ECCO2R is initiated, which is significantly lower than standard lung-protective ventilation (6 mL/kg) 2, 3, 4
  • The reduction to ultra-low tidal volumes (≤3 mL/kg) is feasible in approximately 40% of patients and is more successful with higher ECCO2R blood flow rates (>400 mL/min) 4
  • Document all tidal volumes as mL/kg predicted body weight for standardization 5

Plateau Pressure and Driving Pressure

  • Maintain plateau pressure between 23-25 cmH2O during ECCO2R therapy 2, 3
  • Driving pressure (plateau pressure minus PEEP) should be reduced to approximately 8-12 cmH2O, which represents a significant reduction from conventional protective ventilation 2, 3
  • Continuously assess plateau pressure to ensure lung-protective settings 5

PEEP Management

  • Increase PEEP to 14-15 cmH2O when reducing tidal volumes to maintain alveolar recruitment 2, 3
  • During extracorporeal support, use PEEP greater than 10 cmH2O to maintain alveolar inflation and prevent pulmonary edema and atelectasis 6
  • The higher PEEP compensates for the ultra-low tidal volumes and prevents derecruitment 2

Gas Exchange Targets

CO2 Management

  • Target normocapnia (PaCO2 40-45 mmHg or ETCO2 35-40 mmHg) as the standard approach 7
  • Mild respiratory acidosis is acceptable during ECCO2R initiation, with PaCO2 increases up to 53 mmHg and pH decreases to 7.32 being tolerated 3
  • ECCO2R should be initiated when pH drops below 7.25 with PaCO2 >60 mmHg despite optimized ventilation 1
  • Avoid hyperventilation and hypocapnia (Class III recommendation), as this causes cerebral vasoconstriction and decreased cerebral blood flow, worsening brain ischemia 7

Oxygenation Targets

  • Titrate FiO2 to maintain arterial oxygen saturation of 94-98% once reliable monitoring is established 7
  • Target oxygen saturation of 88-92% in patients with risk factors for hypercapnic respiratory failure 8
  • Avoid early hyperoxia (PaO2 >300 mmHg), which is associated with increased mortality and poor neurological outcomes 6

Respiratory Rate and Minute Ventilation

  • Do not increase respiratory rate to compensate for low tidal volumes during ECCO2R therapy 3
  • The ECCO2R device provides CO2 clearance, eliminating the need for high minute ventilation 2, 3
  • Typical ECCO2R systems remove 50-60 mL/min of CO2 with blood flows of 400-450 mL/min and sweep gas flows of 10 L/min 2, 3

Monitoring Requirements

Continuous Assessment

  • Monitor arterial blood gases every 4-6 hours to assess gas exchange and adjust ventilator settings 8
  • Continuously monitor arterial blood pressure and respiratory parameters 1, 8
  • Assess plateau pressure, PEEP, and auto-PEEP regularly 5
  • Track driving pressure to prevent ventilator-induced injury 5

Daily Evaluations

  • Perform daily echocardiography to assess cardiac function, particularly right ventricular function 8
  • Monitor for signs of left ventricular distension, which can occur with increased afterload 6
  • Track fluid balance meticulously, targeting daily negative fluid balance once hemodynamically stable 6

Critical Pitfalls to Avoid

Hyperventilation

  • Never hyperventilate patients on ECCO2R - this increases intrathoracic pressure, decreases venous return, and worsens cerebral perfusion 7
  • Excessive ventilation with high tidal volumes or rates causes hemodynamic instability and reduces cardiac output 7

Excessive Tidal Volumes

  • Avoid delivering tidal volumes >6 mL/kg when ECCO2R is in place, as this negates the lung-protective benefits 2, 3
  • Use only the force necessary to achieve minimal chest rise 7

Inadequate PEEP

  • Failure to increase PEEP when reducing tidal volumes leads to atelectasis and derecruitment 2
  • PEEP <10 cmH2O is generally insufficient during ultra-protective ventilation with ECCO2R 6

Sedation and Neuromuscular Blockade

  • Administer adequate sedation to reduce oxygen consumption and improve patient-ventilator synchrony 7
  • Short-term neuromuscular blockade (≤48 hours) may be required to prevent patient-ventilator dyssynchrony during ultra-protective ventilation 7
  • Use continuous EEG monitoring if neuromuscular blockade is employed to detect seizures 7
  • Implement sedation protocols with daily interruptions when feasible 7

Weaning Considerations

  • Consider weaning from ECCO2R when PaO2/FiO2 ratio exceeds 200 and the patient can tolerate conventional ventilation settings 2
  • Monitor for rebound hypercapnia in the immediate post-ECCO2R period with arterial blood gases every 4-6 hours 8
  • Gradual weaning of ventilatory support with close monitoring of work of breathing is essential 8

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.